SERETIDE Plus Tiotropium Versus Individual Components

Clinical trial NCT00325169 · COMPLETED

Trial details

NCT number: NCT00325169
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2005-12-01
Primary completion: 2006-08-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.